ArkeaBio
PrivateLast Round
Series A
Extension
Sep 23, 2025
Total Funding Raised
$45.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ArkeaBio is an agricultural biotechnology company developing a vaccine to reduce methane emissions from ruminant animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Carbon Capture
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArkeaBio Comparables
Compare ArkeaBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pasture Biosciences | 91% | |
| Lucidome Bio | 88% | |
| Blue Ocean Barns | 78% |
ArkeaBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 23, 2025 | ||||
| Series A | May 8, 2024 | ||||
| Seed | Dec 12, 2022 |
Key People
Founding team and executive leadership
ArkeaBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Overview Capital | Series A |
| Breakthrough Energy Ventures | Series A Extension, Seed, Series A |
| The Grantham Foundation for the Protection of the Environment | Series A |
| Lowercarbon Capital | Series A |
| Rabo Ventures | Series A |
| AgriZeroNZ | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 184% MoM, reaching 1.4K.
- Sep 23, 2025
Developing a vaccine to reduce methane emissions from livestock.
ArkeaBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ArkeaBio's valuation, stock price, and market status.
Is ArkeaBio a public or private company?
ArkeaBio is a private company.
What is the current stock price of ArkeaBio?
ArkeaBio is a private company with no public stock price. No recent secondary market data is available.
How much is ArkeaBio worth (valuation)?
Valuation information for ArkeaBio is not publicly available.
Can I buy ArkeaBio stock?
ArkeaBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ArkeaBio's last funding round?
ArkeaBio's most recent funding round was Series A Extension on August 28, 2025.
Who are the main investors in ArkeaBio?
Key investors in ArkeaBio include Breakthrough Energy Ventures, AgriZeroNZ.
Will ArkeaBio IPO soon?
No public IPO plans have been announced for ArkeaBio.
How can I track ArkeaBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ArkeaBio's secondary market activity and sign up for updates.